《2023SWAB指南:疑似抗生素过敏的处理方法》解读  

Interpretation of“The Dutch Working Party on Antibiotic Policy(SWAB)guideline for the approach to suspected antibiotic allergy”

作　　者：王润 WANG Run(Honghe Hani and Yi Autonomous Prefecture Hospital of Traditional Chinese Medicine,Honghe 654399,China)

机构地区：[1]红河哈尼族彝族自治州中医医院,云南红河654399

出　　处：《广州医药》2024年第3期262-266,共5页Guangzhou Medical Journal

摘　　要：谨慎处理报告的抗生素过敏是抗生素管理的一个重要方面。荷兰抗生素政策工作组(SWAB)于2023年4月发布了《SWAB指南:疑似抗生素过敏的处理方法》以下简称(指南),指南依据对疑似抗生素过敏人群的比较和结果问题研究,对每个问题进行系统的文献检索,并通过证据评价系统对现有最佳证据进行审查后制定。指南就疑似抗生素交叉过敏,速发型过敏和迟发型过敏等问题进行阐述,为报告抗生素过敏患者选用抗生素治疗的床旁决策提供基于现有研究的循证建议。本文对指南涉及12个关键问题进行解读,以期为疑似抗生素过敏患者临床治疗提供参考,使患者获益。Careful handling of reported antibiotic allergies is an important aspect of antibiotic management.In April 2023,the Dutch Working Group on Antibiotic Policy(SWAB)issued the SWAB Guide:“The Dutch Working Party on Antibiotic Policy(SWAB)guideline for the approach to suspected antibiotic allergy”,hereinafter referred to as“the guide”.According to the intervention,comparison and results of people with suspected antibiotic allergy,the guide systematically searched the literature of each question,and was formulated after reviewing the best evidence available through the evidence evaluation system.The guide elaborated on the suspected cross-allergy,quick-onset allergy and delayed-onset allergy,and selected antibiotics for reporting patients with antibiotic allergy.In this paper,12 key issues involved in the guidelines are interpreted in order to provide reference for clinical treatment of patients suspected of antibiotic allergy and benefit patients.

关 键 词：青霉素 抗生素过敏 Β-内酰胺 氨曲南 碳青霉烯 氟喹诺酮 

分 类 号：R978.1[医药卫生—药品]